Correlation Between Roche Holding and Eli Lilly
Can any of the company-specific risk be diversified away by investing in both Roche Holding and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roche Holding AG and Eli Lilly and, you can compare the effects of market volatilities on Roche Holding and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and Eli Lilly.
Diversification Opportunities for Roche Holding and Eli Lilly
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Roche and Eli is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding AG and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding AG are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Roche Holding i.e., Roche Holding and Eli Lilly go up and down completely randomly.
Pair Corralation between Roche Holding and Eli Lilly
Assuming the 90 days trading horizon Roche Holding AG is expected to generate 0.93 times more return on investment than Eli Lilly. However, Roche Holding AG is 1.08 times less risky than Eli Lilly. It trades about 0.04 of its potential returns per unit of risk. Eli Lilly and is currently generating about 0.0 per unit of risk. If you would invest 512,800 in Roche Holding AG on September 30, 2024 and sell it today you would earn a total of 39,526 from holding Roche Holding AG or generate 7.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.2% |
Values | Daily Returns |
Roche Holding AG vs. Eli Lilly and
Performance |
Timeline |
Roche Holding AG |
Eli Lilly |
Roche Holding and Eli Lilly Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Roche Holding and Eli Lilly
The main advantage of trading using opposite Roche Holding and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.Roche Holding vs. Eli Lilly and | Roche Holding vs. Sanofi | Roche Holding vs. Gilead Sciences | Roche Holding vs. Biogen Inc |
Eli Lilly vs. Roche Holding AG | Eli Lilly vs. Sanofi | Eli Lilly vs. Gilead Sciences | Eli Lilly vs. Biogen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |